Cargando…

Cerebral toxoplasmosis in a diffuse large B cell lymphoma patient

BACKGROUND: Toxoplasmosis is an opportunistic protozoal infection that has, until now, probably been an underestimated cause of encephalitis in patients with hematological malignancies, independent of stem cell or bone marrow transplant. T and B cell depleting regimens are probably an important risk...

Descripción completa

Detalles Bibliográficos
Autores principales: Savsek, Lina, Opaskar, Tanja Ros
Formato: Online Artículo Texto
Lenguaje:English
Publicado: De Gruyter 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4825343/
https://www.ncbi.nlm.nih.gov/pubmed/27069454
http://dx.doi.org/10.1515/raon-2014-0042
_version_ 1782426201392939008
author Savsek, Lina
Opaskar, Tanja Ros
author_facet Savsek, Lina
Opaskar, Tanja Ros
author_sort Savsek, Lina
collection PubMed
description BACKGROUND: Toxoplasmosis is an opportunistic protozoal infection that has, until now, probably been an underestimated cause of encephalitis in patients with hematological malignancies, independent of stem cell or bone marrow transplant. T and B cell depleting regimens are probably an important risk factor for reactivation of a latent toxoplasma infection in these patients. CASE REPORT: We describe a 62-year-old HIV-negative right-handed Caucasian female with systemic diffuse large B cell lymphoma who presented with sudden onset of high fever, headache, altered mental status, ataxia and findings of pancytopenia, a few days after receiving her final, 8(th) cycle of rituximab, cyclophosphamide, vincristine, doxorubicin, prednisolone (R-CHOP) chemotherapy regimen. A progression of lymphoma to the central nervous system was suspected. MRI of the head revealed multiple on T2 and fluid attenuated inversion recovery (FLAIR) hyperintense parenchymal lesions with mild surrounding edema, located in both cerebral and cerebellar hemispheres that demonstrated moderate gadolinium enhancement. The polymerase chain reaction on cerebrospinal fluid (CSF PCR) was positive for Toxoplasma gondii. The patient was diagnosed with toxoplasmic encephalitis and successfully treated with sulfadiazine, pyrimethamine and folic acid. Due to the need for maintenance therapy with rituximab for lymphoma remission, the patient now continues with secondary prophylaxis of toxoplasmosis. CONCLUSIONS: With this case report, we wish to emphasize the need to consider cerebral toxoplasmosis in patients with hematological malignancies on immunosuppressive therapy when presenting with new neurologic deficits. In such patients, there are numerous differential diagnoses for cerebral toxoplasmosis, and the CNS lymphoma is the most difficult among all to distinguish it from. If left untreated, cerebral toxoplasmosis has a high mortality rate; therefore early recognition and treatment are of essential importance.
format Online
Article
Text
id pubmed-4825343
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher De Gruyter
record_format MEDLINE/PubMed
spelling pubmed-48253432016-04-11 Cerebral toxoplasmosis in a diffuse large B cell lymphoma patient Savsek, Lina Opaskar, Tanja Ros Radiol Oncol Case Report BACKGROUND: Toxoplasmosis is an opportunistic protozoal infection that has, until now, probably been an underestimated cause of encephalitis in patients with hematological malignancies, independent of stem cell or bone marrow transplant. T and B cell depleting regimens are probably an important risk factor for reactivation of a latent toxoplasma infection in these patients. CASE REPORT: We describe a 62-year-old HIV-negative right-handed Caucasian female with systemic diffuse large B cell lymphoma who presented with sudden onset of high fever, headache, altered mental status, ataxia and findings of pancytopenia, a few days after receiving her final, 8(th) cycle of rituximab, cyclophosphamide, vincristine, doxorubicin, prednisolone (R-CHOP) chemotherapy regimen. A progression of lymphoma to the central nervous system was suspected. MRI of the head revealed multiple on T2 and fluid attenuated inversion recovery (FLAIR) hyperintense parenchymal lesions with mild surrounding edema, located in both cerebral and cerebellar hemispheres that demonstrated moderate gadolinium enhancement. The polymerase chain reaction on cerebrospinal fluid (CSF PCR) was positive for Toxoplasma gondii. The patient was diagnosed with toxoplasmic encephalitis and successfully treated with sulfadiazine, pyrimethamine and folic acid. Due to the need for maintenance therapy with rituximab for lymphoma remission, the patient now continues with secondary prophylaxis of toxoplasmosis. CONCLUSIONS: With this case report, we wish to emphasize the need to consider cerebral toxoplasmosis in patients with hematological malignancies on immunosuppressive therapy when presenting with new neurologic deficits. In such patients, there are numerous differential diagnoses for cerebral toxoplasmosis, and the CNS lymphoma is the most difficult among all to distinguish it from. If left untreated, cerebral toxoplasmosis has a high mortality rate; therefore early recognition and treatment are of essential importance. De Gruyter 2016-02-16 /pmc/articles/PMC4825343/ /pubmed/27069454 http://dx.doi.org/10.1515/raon-2014-0042 Text en © 2016 Radiol Oncol
spellingShingle Case Report
Savsek, Lina
Opaskar, Tanja Ros
Cerebral toxoplasmosis in a diffuse large B cell lymphoma patient
title Cerebral toxoplasmosis in a diffuse large B cell lymphoma patient
title_full Cerebral toxoplasmosis in a diffuse large B cell lymphoma patient
title_fullStr Cerebral toxoplasmosis in a diffuse large B cell lymphoma patient
title_full_unstemmed Cerebral toxoplasmosis in a diffuse large B cell lymphoma patient
title_short Cerebral toxoplasmosis in a diffuse large B cell lymphoma patient
title_sort cerebral toxoplasmosis in a diffuse large b cell lymphoma patient
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4825343/
https://www.ncbi.nlm.nih.gov/pubmed/27069454
http://dx.doi.org/10.1515/raon-2014-0042
work_keys_str_mv AT savseklina cerebraltoxoplasmosisinadiffuselargebcelllymphomapatient
AT opaskartanjaros cerebraltoxoplasmosisinadiffuselargebcelllymphomapatient